Lmr Partners LLP Sanofi Transaction History

Lmr Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$50.45 - $57.18 $691,165 - $783,366	13,700 New	13,700 $738,000
Q2 2022 Aug 15, 2022	SELL	$48.99 - $57.46 $2.61 Million - $3.06 Million	-53,180 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$48.48 - $53.65 $2.92 Million - $3.23 Million	-60,147 Reduced 53.07%	53,180 $2.73 Million
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $3.22 Million - $3.58 Million	68,327 Added 151.84%	113,327 $5.68 Million
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $2.16 Million - $2.39 Million	45,000 New	45,000 $2.17 Million
Q1 2020 May 15, 2020	SELL	$38.02 - $51.66 $504,791 - $685,889	-13,277 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $587,507 - $675,268	13,277 New	13,277 $666,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.